About - INTEGRATE EU

Would you like to join our consortium as a Doctoral Candidate (DC)?
All sixteen positions will be opening soon – follow this website closely for announcements and application details.

About INTEGRATE

Psychedelic Insights

Our research focuses on understanding the mechanisms of psychedelic substances and their therapeutic potential. We aim to uncover how these agents can contribute to mental health solutions, fostering innovative approaches in psychotherapy.

Collaborative Research

We promote collaborative projects that unite researchers from diverse backgrounds. By sharing resources and knowledge, we enhance the quality and impact of our studies on psychedelic therapy and patient care.

Training Opportunities

We provide a range of professional development programs for early-career researchers. Our training enhances skills in psychedelic research methodologies and paves the way for future breakthroughs in mental health.

Key Achievements of Our Consortium

We’ve made significant strides in psychedelic therapy research, helping advance science and societal understanding.

Research Papers Published

0

Collaborative Projects Launched

0 +

Foundational Grants Secured

0 +

International Conferences Attended

0 +

Meet Our Experts

Discover the Supervisors Behind INTEGRATE's Groundbreaking Research.

Dr. Jane Smith specializes in psychedelic therapies and mental health research, aiming to transform lives with her innovative approach.

Prof. John Doe leads pioneering research in psychedelic therapy, focusing on effective treatment strategies and scientific integrity.

Dr. Emily Brown’s expertise in neuroscience supports the development of therapies aimed at enhancing mental health outcomes.

Prof. Mark Lee conducts advanced studies in psychedelic therapy, emphasizing collaboration to improve therapeutic frameworks.

Explore Our Collaborative Network

INTEGRATE Partners

Beneficiaries

Associated partners

Associated partners linked to a beneficiary

Consortium on the map